Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients [Phase 2]

View source ↗

Summary

A Phase 2 study of SYHX1901 Tablet for non-segmental vitiligo is ongoing and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• SYHX1901 Tablet

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Non-segmental Vitiligo | Phase 2 | Status: RECRUITING